Mon 11/27/2023 22:40 PM
Share this article:
Relevant Documents:
Medco $500M 8.96% Senior Notes due 2029 OC, or due ‘29 OC
Medco 9M’23 Financials
Medco 9M’23 Presentation
Medco 1H’23 Presentation
Tear Sheet in Excel on Reorg Analysis Page
Reorg Asia Highlights



  • While Medco’s USD notes have outperformed over the past two years, prices already reflect at least a one-notch upgrade to BB- equivalent and may not be pricing in potential oil price weakness, M&A and contract renewal risks;


  • Medco faces challenges in...
Share this article:
This article is an example of the content you may receive if you subscribe to a product of Reorg Research, Inc. or one of its affiliates (collectively, “Reorg”). The information contained herein should not be construed as legal, investment, accounting or other professional services advice on any subject. Reorg, its affiliates, officers, directors, partners and employees expressly disclaim all liability in respect to actions taken or not taken based on any or all the contents of this publication. Copyright © 2024 Reorg Research, Inc. All rights reserved.
Thank you for signing up
for Reorg on the Record!